High-throughput screening: it is a technique that allows the testing of thousands of compounds in a short time, identifying those that have antiviral activity.

Use of broad-spectrum antivirals: these drugs are effective against several types of viruses, reducing the need for specific antivirals for each virus.

Repurposing of drugs: it consists of testing drugs that are already approved for other diseases, but that may have antiviral activity.

Virtual screening of molecules: through software and algorithms, it is possible to perform a virtual screening of thousands of compounds in search of those that have greater affinity with the viral target, reducing the time and costs of the process of discovering new antivirals.

Structure-activity studies: it investigates the relationship between the molecular structure of compounds and their antiviral activities, allowing the identification of functional groups and structural characteristics that are important for the efficacy of antivirals.